India races to have vaccine ready by Aug 15

Breaking: COVID-19 vaccine by Aug 15 likely; ICMR, Bharat Biotech join hands

Here Is When India's First Coronavirus Vaccine Is Coming

And that the vaccine will be launched on 15th August?

The letter also warns these hospitals that non-compliance will be viewed very seriously.

Typical vaccine development can take as long as a decade.

In fact, in his Mann ki Baat Twitter handle, he recently wrote, "Work being done in our labs on Corona vaccine is being keenly observed by the world and we are hopeful too".

Florida breaks daily COVID-19 record with more than 10,000 new cases
Meanwhile, the government reported that USA unemployment fell to 11.1% in June as the economy added a solid 4.8 million jobs. India has reported almost 100,000 new cases in the past four days alone. "We are not out of this disaster".


Bhubaneswar-based Institute of Medical Sciences and SUM Hospital under the SOA Deemed to be University, has been chosen by the Indian Council for Medical Research (ICMR) for undertaking human clinical trials of India's first coronavirus vaccine, an official of the institute said.

"As a principal investigator, I would not move unless I get a clearance, let it be anyone who is telling".

A vaccine ready for public use will allow the safe reopening of schools, offices and factories to revive India's economy, which is hurtling toward its first contraction in more than four decades. Besides Covaxin, and ZyCoV-D, five more vaccines, including that of Serum Institute of India and Panacea Biotec, are being researched in India.

ZyCoV-D, developed at the company's Vaccine Technology Centre in Ahmedabad, has now received permission from the DGCI-Central Drugs Standard Control Organisation to initiate phase I/II human clinical trials in India, Cadila Healthcare said. It was cleared for Phase I and II clinical trials by Drugs Controller General of India (DCGI) only a few days ago after scrutiny of the available data from pre-clinical studies.

China identifies new swine flu with pandemic potential
But it's important to understand that, as yet, there is no evidence of human-to-human transmission of this particular virus. The tests showed that as many as 4.4 per cent of the general population also appeared to have been exposed.


Phase 2 trials often involve several hundred subjects, and mainly evaluate the efficacy. "Recruitment of participants in itself can take months even if we try to expedite everything like we are doing for Covid-19", said Anant Bhan, a researcher in bioethics and global health.

Seventeen vaccine candidates, across at least ten countries, are already undergoing clinical trials. Clinical trial of this drug will be done on 1000 volunteers.

US-based Moderna (in collaboration with federal research institutions) last month started Phase 2 trials for its candidate. "Even with accelerated timelines, this seems really rushed, and hence with potential risks, inadequate attention to process". Inactivated vaccines used against SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndromme) had led to poorly regulated inflammatory responses or cytokine storms where the immune system overreacts. Facing backlash, ICMR assured that the fast-tracked vaccine development process adheres to globally accepted norms while negating hindrances due to red tape and "slow file movement".

After intense characterization and review of all data from BBIL, ICMR said it is supporting the clinical development as the vaccine candidate appears to be promising.

La bataille judiciaire autour de l'héritage de Johnny Hallyday est terminée
La veuve de la star affirme dans un communiqué être ravie de voir que la fille du Taulier ait " saisi la main tendue ". Nous n'avons rien demandé, il est donc normal que nous ne fassions pas partie de cet accord.


Latest News